NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROPULSID QUICKSOLV (cisapride monohydrate) is an orally disintegrating tablet formulation of cisapride, a prokinetic agent approved by the FDA in 1997. The product is designed to enhance gastric motility and accelerate gastric emptying in patients with gastrointestinal dysmotility. It addresses symptomatic relief in conditions characterized by delayed gastric transit.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), team focus is likely shifting toward lifecycle extension strategies and managed decline rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROPULSID QUICKSOLV offers limited growth opportunity but provides valuable experience in late-lifecycle brand management, generic transition planning, and cost-containment strategies. Roles on this product are typically focused on maximizing profitability during decline rather than market expansion, making it suitable for professionals seeking to develop expertise in lifecycle management.
Brand Manager
Worked on PROPULSID QUICKSOLV at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.